Freya Biosciences
Driving immune-mediated therapeutic innovation for women. Freya focuses on the underlying drivers of disease, not just symptoms.
$38M Series A ·
Led by OMX Ventures · Source: fundraisingfox.com
Latest round on record: Series A, November 2024, amount undisclosed.
All 2 rounds ↓Signals
Website registeredFeb 29, 2020 (6 years old)
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Series A · $38M
OOMX Ventures (lead),
SSofinnova Partners (lead),
AAngelini Ventures,
CCE Ventures (CEIIF),
CCorundum Systems Biology,
EExport and Investment Fund,
IIndaco Venture Partners, MMike Jafar Family Office
Source: fundraisingfox.com - Website created
Founders and team
- CAColleen Acosta CEO, Co-Foundersource: freyabiosciences.com
JV
Johan van Hylckama Vlieg CSO, Co-Foundersource: freyabiosciences.com
Investors
AAngelini Ventures
BBill & Melinda Gates Foundation
CCE Ventures (CEIIF)
CCorundum Systems Biology
EExport and Investment Fund
IIndaco Venture Partners
- MMike Jafar Family Office
OOMX Ventureslead investor
SSofinnova Partnerslead investor
Companies like Freya Biosciences
HHI-Bio$95M Series B+ · Jan 2024
MMirador Therapeutics$250M Series B+ · Jan 2026
OOuro Medicines$120M Series A · Jan 2025
EEngimmune Therapeutics$16M Seed · May 2022BBionyra$165M Series A · Jun 2026
KKhartis Therapeutics$95M Series B+ · Aug 2026
Other companies backed by OMX Ventures
LLightcast$27M Series B+ · Apr 2026
VVedaBio$25M Series A · Sep 2025
MMRM Health$64.12M Series B+ · Sep 2025
CConstructive Bio$58M Series A · Sep 2024
OOverT Bio$16M Seed · May 2024
DDelixSeries A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/freya-biosciences (get a free API key).